↓ Skip to main content

CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics

Overview of attention for article published in Cancer Cell International, January 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Published in
Cancer Cell International, January 2019
DOI 10.1186/s12935-019-0726-0
Pubmed ID
Authors

Debarati Ghosh, Prabhadevi Venkataramani, Saikat Nandi, Sonali Bhattacharjee

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 80 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 18%
Student > Bachelor 13 16%
Student > Master 12 15%
Student > Doctoral Student 5 6%
Researcher 5 6%
Other 5 6%
Unknown 26 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 26 33%
Agricultural and Biological Sciences 5 6%
Social Sciences 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Materials Science 3 4%
Other 12 15%
Unknown 27 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2019.
All research outputs
#13,118,420
of 23,122,481 outputs
Outputs from Cancer Cell International
#657
of 1,828 outputs
Outputs of similar age
#202,809
of 438,093 outputs
Outputs of similar age from Cancer Cell International
#5
of 24 outputs
Altmetric has tracked 23,122,481 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,828 research outputs from this source. They receive a mean Attention Score of 3.9. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,093 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.